News

Podcast

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Author(s):

Alexandra Gerlach, Associate Editor

Pharmacists share key insights about the use of ADCs for treatment of breast cancer.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
HRT Hormone Therapy sign surrounded by plants and hormone therapy pills | Image Credit: © tilialucida - stock.adobe.com
July 2nd 2025

Study Links Specific Hormone Therapies to Breast Cancer Risk in Younger Women

Alexandra Gerlach, Associate Editor
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
3d illustration of the heart and lung
July 2nd 2025

Lung Transplant Recipients at High Risk of Secondary Lung Infections Post-Infection With SARS-CoV-2 Omicron Variant

Luke Halpern, Assistant Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Sepsis - Image credit: Zerbor | stock.adobe.com
July 2nd 2025

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Kennedy Ferruggia, Assistant Editor
Visualization of CAR T-cell among red blood cells | Image Credit: © Olha - stock.adobe.com
July 1st 2025

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

Alexandra Gerlach, Associate Editor